Literature DB >> 2502242

Tamoxifen-warfarin interaction: the Aberdeen hospitals drug file.

L D Ritchie1, S M Grant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2502242      PMCID： PMC1836243          DOI： 10.1136/bmj.298.6682.1253

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  A hospital based drug information system.

Authors:  D C Moir; E R Alexander; J W Barnett; L J Christopher
Journal:  Health Bull (Edinb)       Date:  1975-03

2.  Life threatening interaction between tamoxifen and warfarin.

Authors:  P Tenni; D L Lalich; M J Byrne
Journal:  BMJ       Date:  1989-01-14
  2 in total
  8 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

2.  Quantitative studies of allosteric effects by biointeraction chromatography: analysis of protein binding for low-solubility drugs.

Authors:  Jianzhong Chen; David S Hage
Journal:  Anal Chem       Date:  2006-04-15       Impact factor: 6.986

Review 3.  Antineoplastic agents. Drug interactions of clinical significance.

Authors:  E van Meerten; J Verweij; J H Schellens
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

4.  Effect of toremifene on antipyrine elimination in the isolated perfused rat liver.

Authors:  L K Webster; A G Ellis; J F Bishop
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 5.  Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.

Authors:  V C Jordan
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

6.  Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs.

Authors:  R W F van Leeuwen; D H S Brundel; C Neef; T van Gelder; R H J Mathijssen; D M Burger; F G A Jansman
Journal:  Br J Cancer       Date:  2013-02-14       Impact factor: 7.640

7.  Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4.

Authors:  Shufeng Zhou; Eli Chan; Xiaotian Li; Min Huang
Journal:  Ther Clin Risk Manag       Date:  2005-03       Impact factor: 2.423

8.  Hypercoagulation from Concomitant Administration of Tamoxifen and Warfarin.

Authors:  Ladan Panahi; Javier A Saenz Ii; Nam Nguyen; George Udeani; Salim Surani
Journal:  Cureus       Date:  2020-05-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.